Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Trends in Cancer|September 30, 2017
Imaging Tunneling Membrane Tubes Elucidates Cell Communication in TumorsEmil Lou, Sepideh Gholami, Yevgeniy Romin, et al.
Frontiers in Physiology|November 18, 2014
Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubesJustin W Ady, Snider Desir, Venugopal Thayanithy, et al.
Neuro-Oncology Advances|July 13, 2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating FieldsManjari Pandey, Joanne Xiu, Sandeep Mittal, et al.
Elife|November 13, 2023
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesotheliomaAkshat Sarkari, Sophie Korenfeld, Karina Deniz, et al.
Hepatobiliary Surgery and Nutrition|June 9, 2020
Systemic therapy without radiation may be appropriate as neoadjuvant therapy for localized pancreas cancerScott Kizy, Ariella M Altman, Keith M Wirth, et al.
The Oncologist|September 18, 2024
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trialMarie S Dreyer, Mary Mulcahy, Masha Kocherginsky, et al.
NPJ Precision Oncology|July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancerLawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 5, 2013
Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancerSepideh Gholami, Chun-Hao Chen, Emil Lou, et al.
Scientific Reports|June 23, 2018
Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic CancerSnider Desir, Patrick O'Hare, Rachel Isaksson Vogel, et al.
BJC Reports|February 6, 2026
STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancerArpit Aggarwal, Morgann Madill, Mayukhmala Jana, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Trends in Cancer|September 30, 2017
Imaging Tunneling Membrane Tubes Elucidates Cell Communication in TumorsEmil Lou, Sepideh Gholami, Yevgeniy Romin, et al.
Frontiers in Physiology|November 18, 2014
Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubesJustin W Ady, Snider Desir, Venugopal Thayanithy, et al.
Neuro-Oncology Advances|July 13, 2022
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating FieldsManjari Pandey, Joanne Xiu, Sandeep Mittal, et al.
Elife|November 13, 2023
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesotheliomaAkshat Sarkari, Sophie Korenfeld, Karina Deniz, et al.
Hepatobiliary Surgery and Nutrition|June 9, 2020
Systemic therapy without radiation may be appropriate as neoadjuvant therapy for localized pancreas cancerScott Kizy, Ariella M Altman, Keith M Wirth, et al.
The Oncologist|September 18, 2024
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trialMarie S Dreyer, Mary Mulcahy, Masha Kocherginsky, et al.
NPJ Precision Oncology|July 17, 2025
Multi-omic characterization of early-onset esophagogastric cancerLawrence W Wu, Sachin Kumar Deshmukh, Sharon Wu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 5, 2013
Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancerSepideh Gholami, Chun-Hao Chen, Emil Lou, et al.
Scientific Reports|June 23, 2018
Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic CancerSnider Desir, Patrick O'Hare, Rachel Isaksson Vogel, et al.
BJC Reports|February 6, 2026
STAR (stroma-tumor AI risk) assessment: association of AI-derived tumor-stroma proportion with patient survival provides added prognostic value beyond KELIM in epithelial ovarian cancerArpit Aggarwal, Morgann Madill, Mayukhmala Jana, et al.
Pageof 19